Adrian Milota
About Adrian Milota
Adrian Milota is a Product Specialist Multiple Sclerosis at Bristol Myers Squibb in Darmstadt, Germany, with over 15 years of experience in the pharmaceutical industry.
Title and Current Role
Adrian Milota serves as a Product Specialist Multiple Sclerosis at Bristol Myers Squibb. He is based in Darmstadt, Hessen, Deutschland, where he applies his extensive background in pharmaceuticals to his current specialization in multiple sclerosis.
Previous Experience
Before his current role, Adrian worked as a Sales Specialist Hematooncology at Bristol Myers Squibb from 2017 to 2020 in Darmstadt und Umgebung. He also held the position of Oncology Specialist at Shire from 2016 to 2017, covering regions such as Darmstadt, Frankfurt, Heidelberg, Mannheim, and Saarbrücken. Prior to that, he served as Fachreferent im Außendienst at Vifor Pharma from 2013 to 2016 and as Sales / Business Development Manager at Humatrix in 2012 for a brief period of 5 months. His earlier career includes a significant role as Außendienst at Nycomed from 2007 to 2012.
Education and Expertise
Adrian Milota holds a Master of Business Administration (MBA) from FOM Hochschule für Oekonomie & Management, which he completed from 2010 to 2013. He also earned a Diplom Biologe from Universität Konstanz, studying there from 2001 to 2006. His academic background equips him with a strong foundation in both biology and business administration, allowing him to merge scientific knowledge with business acumen effectively.
Pharmaceutical Industry Background
Adrian Milota has amassed over 15 years of experience in the pharmaceutical industry. He has transitioned from roles in sales and business development to specialized positions focusing on multiple sclerosis and oncology. His multifaceted career reflects his adaptability and deep-rooted expertise in the sector.
Regional Experience
Throughout his career, Adrian has worked in various regions, including Darmstadt, Frankfurt, Heidelberg, Mannheim, and Saarbrücken. This diverse regional experience has provided him with a broad perspective and deep understanding of the pharmaceutical markets in these areas.